Skip to main content
Log in

Thrombotic thrombocytopenic purpura in a patient with lenalidomide-responsive multiple myeloma

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

References

  1. George JN (2015) Measuring ADAMTS13 activity in patients with suspected thrombotic thrombocytopenic purpura: when, how, and why? Transfusion 55:11–13

    Article  PubMed  Google Scholar 

  2. Ferrari S, Scheiflinger F, Rieger M et al (2007) Prognostic value of anti-ADAMTS 13 antibody features (Ig isotype, titer, and inhibitory effect) in a cohort of 35 adult French patients undergoing a first episode of thrombotic microangiopathy with undetectable ADAMTS 13 activity. Blood 109:2815–2822

    CAS  PubMed  Google Scholar 

  3. Kornacker M, Luft T, Ho AD et al (2005) Thrombotic microangiopathy after combined autografting-allografting for multiple myeloma - report of three cases. Eur J Haematol 74:250–253

    Article  CAS  PubMed  Google Scholar 

  4. Gallerani E, Lerch E, Romagnani E et al (2006) Thrombotic thrombocytopenic purpura associated with renal failure after autologous transplantation for multiple myeloma successfully treated with rituximab. Eur J Haematol 77:527–529

    Article  PubMed  Google Scholar 

  5. Munoz J, Hughes A (2012) Thrombotic thrombocytopenic purpura after autologous peripheral stem cell transplantation. Blood 119:5620

    Article  PubMed  Google Scholar 

  6. Nakamura Y, Mitani N, Ishii A et al (2013) Idiopathic pneumonia syndrome with thrombotic microangiopathy-related changes after allogeneic hematopoietic stem cell transplantation. Int J Hematol 98:496–498

    Article  PubMed  Google Scholar 

  7. Peffault de Latour R, Xhaard A, Fremeaux-Bacchi V et al (2013) Successful use of eculizumab in a patient with post-transplant thrombotic microangiopathy. Br J Haematol 161:279–280

    Article  PubMed  Google Scholar 

  8. Morita R, Hashino S, Shirai S et al (2008) Thrombotic microangiopathy after treatment with bortezomib and dexamethasone in a patient with multiple myeloma. Int J Hematol 88:248–250

    Article  PubMed  Google Scholar 

  9. Moore H, Romeril K (2011) Multiple myeloma presenting with a fever of unknown origin and development of thrombotic thrombocytopenic purpura post-bortezomib. Intern Med J 41:348–350

    Article  CAS  PubMed  Google Scholar 

  10. Mehta N, Saxena A, Niesvizky R (2012) Bortezomib-induced thrombotic thrombocytopaenic purpura. BMJ Case Rep: 2012

  11. Salmenniemi U, Remes K (2012) Thrombotic microangiopathy associated with bortezomib treatment in a patient with relapsed multiple myeloma. Hematol Rep 4:e13

    PubMed Central  PubMed  Google Scholar 

  12. Chan KL, Filshie R, Nandurkar H et al. (2015) Thrombotic microangiopathy complicating bortezomib-based therapy for multiple myeloma. Leuk Lymphoma:1–2

  13. Hobeika L, Self SE, Velez JC (2014) Renal thrombotic microangiopathy and podocytopathy associated with the use of carfilzomib in a patient with multiple myeloma. BMC Nephrol 15:156

    Article  PubMed Central  PubMed  Google Scholar 

  14. Sullivan MR, Danilov AV, Lansigan F et al. (2014) Carfilzomib associated thrombotic microangiopathy initially treated with therapeutic plasma exchange. J Clin Apher

  15. Xu B, Ritchie D (2010) Thrombotic thrombocytopenic purpura associated with disseminated varicella zoster in a multiple myeloma patient. Intern Med J 40:e7–e8

    Article  CAS  PubMed  Google Scholar 

  16. Xiao X, Zhong HY, Zhang GS et al (2013) Thrombotic thrombocytopenic purpura as initial and major presentation of multiple myeloma. J Thromb Thrombolysis 36:422–423

    Article  PubMed  Google Scholar 

  17. Lechner K, Obermeier HL (2012) Cancer-related microangiopathic hemolytic anemia: clinical and laboratory features in 168 reported cases. Medicine (Baltimore) 91:195–205

    Article  Google Scholar 

  18. Hofmeister CC, Jin M, Cataland SR et al (2010) TTP disease course is independent of myeloma treatment and response. Am J Hematol 85:304–306

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgments

This work was not supported by any grants.

Conflict of interest

The authors declare no conflicts of interest.

Informed consent

The patient in question gave written informed consent for her participation in this study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chan Yoon Cheah.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cheah, C.Y., Orlowski, R.Z., Manasanch, E.E. et al. Thrombotic thrombocytopenic purpura in a patient with lenalidomide-responsive multiple myeloma. Ann Hematol 94, 1605–1607 (2015). https://doi.org/10.1007/s00277-015-2421-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-015-2421-0

Keywords

Navigation